Lino Biotech
SwitzerlandEntry
2020
Hold
3yr
Exit
2023
Who owns Lino Biotech?
Lino Biotech was owned by High-Tech Gruenderfonds (HTGF) through HTGF III (2017 vintage) from 2020 to 2023, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-11
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023
More from HTGF III
Other portfolio companies in the same fund.
Germany
United KingdomMore PE-backed in MedTech
Comparable medtech deals from other GPs.
France
Track Lino Biotech
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Lino Biotech.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue